-
Loading metrics
Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium
- Alicia Rovó,
- Nathan Cantoni,
- Kaveh Samii,
- Axel Rüfer,
- Giedre Koenen,
- Sandra Ivic,
- Davide Cavanna,
- Rudolf Benz
x
- Published: April 21, 2022
- https://doi.org/10.1371/journal.pone.0267342